Claire O’Leary

1.7k total citations
44 papers, 1.2k citations indexed

About

Claire O’Leary is a scholar working on Physiology, Epidemiology and Neurology. According to data from OpenAlex, Claire O’Leary has authored 44 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Physiology, 11 papers in Epidemiology and 7 papers in Neurology. Recurrent topics in Claire O’Leary's work include Lysosomal Storage Disorders Research (13 papers), Trypanosoma species research and implications (5 papers) and Autoimmune and Inflammatory Disorders Research (4 papers). Claire O’Leary is often cited by papers focused on Lysosomal Storage Disorders Research (13 papers), Trypanosoma species research and implications (5 papers) and Autoimmune and Inflammatory Disorders Research (4 papers). Claire O’Leary collaborates with scholars based in United Kingdom, Ireland and Australia. Claire O’Leary's co-authors include Patrick G. Holt, K. Krska, Brian Bigger, Rebecca Holley, John L. Waddington, Colm O’Tuathaigh, Orna Tighe, Richard P. Harvey, Hélène F.E. Gleitz and Lieve Desbonnet and has published in prestigious journals such as The Lancet, PLoS ONE and Brain.

In The Last Decade

Claire O’Leary

43 papers receiving 1.1k citations

Peers

Countries citing papers authored by Claire O’Leary

Since Specialization

Citations

This map shows the geographic impact of Claire O’Leary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire O’Leary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire O’Leary more than expected).

Fields of papers citing papers by Claire O’Leary

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claire O’Leary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire O’Leary. The network helps show where Claire O’Leary may publish in the future.

Co-authorship network of co-authors of Claire O’Leary

This figure shows the co-authorship network connecting the top 25 collaborators of Claire O’Leary. A scholar is included among the top collaborators of Claire O’Leary based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claire O’Leary. Claire O’Leary is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Establishment of the Effectiveness of Early Versus Late Stem Cell Gene Therapy in Mucopolysaccharidosis II for Treating Central Versus Peripheral Disease 2023 ·Human Gene Therapy ·(unknown), Aiyin Liao, Esha Singh, Claire O’Leary, Rebecca Holley, Brian Bigger	5
2	Fusion of Rabies Virus Glycoprotein or gh625 to Iduronate-2-Sulfatase for the Treatment of Mucopolysaccharidosis Type II 2023 ·Human Gene Therapy ·(unknown), (unknown), Stuart Ellison, (unknown), (unknown), (unknown), Gabriella Forte, Claire O’Leary, Hélène F.E. Gleitz, Aiyin Liao, James Cook, Rebecca Holley, Brian Bigger	2
3	The Environment as an Object Relationship: A Two-Part Study 2022 ·Ecopsychology ·(unknown), (unknown), Patrick O’Neill, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Claire O’Leary, (unknown), (unknown)	5
4	The spatial phenotype of genotypically distinct meningiomas demonstrate potential implications of the embryology of the meninges 2020 ·Oncogene ·Daniel M. Fountain, Miriam J. Smith, Claire O’Leary, Omar Pathmanaban, Federico Roncaroli, Nicoletta Bobola, Andrew T. King, D. Gareth Evans	19
5	Anakinra in COVID-19: important considerations for clinical trials 2020 ·The Lancet Rheumatology ·Andrew T. King, Andy Vail, Claire O’Leary, Cathal John Hannan, David Brough, Hiren C. Patel, James Galea, Kayode Ogungbenro, (unknown), Omar Pathmanaban, Sharon Hulme, Stuart M. Allan	40
6	Value of dynamic clinical and biomarker data for mortality risk prediction in COVID-19: a multicentre retrospective cohort study 2020 ·BMJ Open ·Carlo Berzuini, Cathal John Hannan, Andrew T. King, Andy Vail, Claire O’Leary, David Brough, James Galea, Kayode Ogungbenro, (unknown), Omar Pathmanaban, Sharon Hulme, Stuart M. Allan, Luisa Bernardinelli, Hiren C. Patel	13
7	Haematopoietic stem cell gene therapy with IL ‐1Ra rescues cognitive loss in mucopolysaccharidosis IIIA 2020 ·EMBO Molecular Medicine ·Helen Parker, Stuart Ellison, Rebecca Holley, Claire O’Leary, Aiyin Liao, (unknown), (unknown), Arunabha Ghosh, Simon Jones, Fiona L. Wilkinson, David Brough, Emmanuel Pinteaux, Hervé Boutin, Brian Bigger	39
8	An improved AAV vector for neurological correction of the mouse model of Mucopolysaccharidosis IIIA 2019 ·UCL Discovery (University College London) ·(unknown), Claire O’Leary, (unknown), José A. G. Agúndez, (unknown), (unknown), Helen Parker, (unknown), Olivier Danos, Michaël Hocquemiller, (unknown), (unknown), Els Henckaerts, (unknown), Brian Bigger	1
9	Non-myeloablative busulfan chimeric mouse models are less pro-inflammatory than head-shielded irradiation for studying immune cell interactions in brain tumours 2019 ·Journal of Neuroinflammation ·(unknown), (unknown), Claire O’Leary, Gabriella Forte, Helen Parker, Aiyin Liao, Brian A. Telfer, Kaye J. Williams, Ian Kamaly-Asl, Brian Bigger	16
10	Strategies for the Induction of Immune Tolerance to Enzyme Replacement Therapy in Mucopolysaccharidosis Type I 2019 ·Molecular Therapy — Methods & Clinical Development ·Arunabha Ghosh, Aiyin Liao, Claire O’Leary, Jean Mercer, Karen Tylee, Anu Goenka, Rebecca Holley, Simon Jones, Brian Bigger	10
11	An Improved Adeno-Associated Virus Vector for Neurological Correction of the Mouse Model of Mucopolysaccharidosis IIIA 2019 ·Human Gene Therapy ·Anna L. Gray, Claire O’Leary, Aiyin Liao, (unknown), (unknown), Hélène F.E. Gleitz, Helen Parker, (unknown), Olivier Danos, Michaël Hocquemiller, (unknown), R. Michael Linden, Els Henckaerts, Rebecca Holley, Brian Bigger	14
12	Timed colonoscopy withdrawal, a mandatory quality measure in the era of national screening? 2018 ·Irish Journal of Medical Science (1971 -) ·(unknown), Claire O’Leary, (unknown)	3
13	Identification of age-dependent motor and neuropsychological behavioural abnormalities in a mouse model of Mucopolysaccharidosis Type II 2017 ·PLoS ONE ·Hélène F.E. Gleitz, Claire O’Leary, Rebecca Holley, Brian Bigger	20
14	Motor and behavioral phenotype in conditional mutants with targeted ablation of cortical D1 dopamine receptor-expressing cells 2015 ·Neurobiology of Disease ·(unknown), Claire O’Leary, Hyun Ah Kim, Clare L. Parish, Jim S. Massalas, John L. Waddington, Michelle E. Ehrlich, Gunter M. Schütz, Ilse Gantois, Andrew J. Lawrence, John Drago	9
15	Phenotypic effects of maternal immune activation and early postnatal milieu in mice mutant for the schizophrenia risk gene neuregulin-1 2014 ·Neuroscience ·Claire O’Leary, Lieve Desbonnet, Niamh Clarke, Emilie Petit, Orna Tighe, (unknown), Richard P. Harvey, John L. Waddington, Colm O’Tuathaigh	54
16	Resolving pathobiological mechanisms relating to Huntington disease: Gait, balance, and involuntary movements in mice with targeted ablation of striatal D1 dopamine receptor cells 2013 ·Neurobiology of Disease ·Hyun Ah Kim, (unknown), Heather B. Madsen, Clare L. Parish, Jim S. Massalas, (unknown), Claire O’Leary, Ilse Gantois, Colm O’Tuathaigh, John L. Waddington, Michelle E. Ehrlich, Andrew J. Lawrence, John Drago	11
17	Neuronal glycosylation differentials in normal, injured and chondroitinase-treated environments 2012 ·Biochemical and Biophysical Research Communications ·Michelle Kilcoyne, (unknown), (unknown), Claire O’Leary, Lokesh Joshi, Siobhán S. McMahon	16
18	Genetic vs. pharmacological inactivation of COMT influences cannabinoid-induced expression of schizophrenia-related phenotypes 2011 ·The International Journal of Neuropsychopharmacology ·Colm O’Tuathaigh, Gerard Clarke, Jeremy Walsh, Lieve Desbonnet, Emilie Petit, Claire O’Leary, Orna Tighe, Niamh Clarke, Maria Karayiorgou, Joseph A. Gogos, Timothy G. Dinan, John F. Cryan, John L. Waddington	47
19	Coeliac disease and autoimmune Addison's disease: a clinical pitfall 2002 ·QJM ·Claire O’Leary	68
20	Single-Dose Pharmacokinetics of Madopar HBS in Patients and Effect of Food and Antacid on the Absorption of Madopar HBS in Volunteers 1987 ·European Neurology ·S.L. Malcolm, John G. Allen, (unknown), Niall Quinn, (unknown), C. D. Marsden, Claire O’Leary	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact